Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-55
SponsorAdventHealth Translational Research Institute

About this trial

The overall aim of this study is to investigate the effects of exercise on the amount of glucose that is made by the liver in people with and without Type 2 diabetes (T2D) and hepatic steatosis (fatty liver).

Eligibility criteria

Qualifiers

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and availability for the duration of the study

Male or (pre-menopausal) female, aged 25-55 years

Body mass index (BMI) between 25 and 45 kg/m2

Disqualifiers

Exclusion criteria for individuals with T2D and elevated liver fat ≥5.6% Currently taking insulin, incretin mimetics, and/or thiazolidinediones

Any change in glucose-lowering medications within the previous three months.

Inability to stop any medications which interfere with glucose metabolism for visits 4 and 7.

Resting blood pressure ≥ 160/100 mm Hg

Trial design

Treatments tested in this trial

  • Magnetic Resonance Liver Assessment
  • Bike Exercise VO2max
  • DEXA

Treatment groups

12 Participants
are divided into 2 treatment groups